Close this window

Transaction in Own Shares

06/09/2026
RNS Number : 4012H
Fevertree Drinks PLC
09 June 2026
 

9th June 2026                         

Fevertree Drinks plc

("Fever-Tree" or the "Company")

Transaction in Own Shares

 

Fevertree Drinks plc ("Fever-Tree" or the "Company") announces today it has, in accordance with the authority granted by shareholders at its 2025 Annual General Meeting held on 5th June, purchased the following number of ordinary shares of £0.0025 each in the Company (the "Ordinary Shares") through the Company's broker, Investec Bank plc ("Investec") in the period from 1st June to 5th June 2026.

Date

Venue

Volume-weighted average price (p)

Aggregated volume

Lowest price per share (p)

Highest price per share (p)

01 June 2026

XLON

768.4415

           24,843

760.0000

781.0000

01 June 2026

AIMX

771.0000

           20,000

771.0000

771.0000

02 June 2026

XLON

756.1103

           44,120

746.0000

767.5000

03 June 2026

XLON

750.5514

           26,893

745.0000

758.0000

04 June 2026

XLON

746.6340

           40,668

740.5000

753.0000

04 June 2026

AIMX

746.5000

             3,364

746.5000

746.5000

05 June 2026

XLON

750.9454

           25,477

740.0000

758.0000

05 June 2026

AIMX

756.5000

           30,000

756.5000

756.5000

 

The Company intends to cancel the purchased shares.

   

Schedule of Purchases - Individual Transactions

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation) (which forms part of domestic UK law by virtue of the European Union (Withdrawal) Act 2018, as amended), a full breakdown of the individual trades made by Investec on behalf of the Company as part of the share buyback programme is attached to this announcement.

 

http://www.rns-pdf.londonstockexchange.com/rns/4012H_1-2026-6-8.pdf

 

This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.

 

For further information please contact:

 

Investor queries

Steve Nightingale, Director of Investor Relations I steve.nightingale@fever-tree.com I +44 (0)7951 849564

 

Media queries

Oliver Winters, Director of Communications I oliver.winters@fever-tree.com I +44 (0)770 332 9024  

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSKVLBBQQLBBBE

Multimedia Files:

Close this window